Statements of operations - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Revenue:
Revenues	$ 33,396	$ 28,310
Expenses:
Cost of revenue (excluding depreciation and amortization)	4,734	3,996
Payment processing expense	6,848	6,949
Sales and marketing	9,434	7,702
Research and development	5,005	4,299
General and administrative	8,720	6,245
Depreciation	2,268	2,155
Amortization	1,353	1,219
Total expenses	38,362	32,564
Operating loss	(4,966)	(4,255)
Other income (expense)	(715)	(1,145)
Change in fair value of warrant liability	0	(423)
Interest income (expense)	(320)	(804)
Total other income (expense)	(1,035)	(2,372)
Loss before provision for income taxes	(6,001)	(6,627)
Provision for income taxes	(111)	(68)
Net loss	(6,112)	(6,695)
Accretion of redeemable preferred stock	0	(7,863)
Net loss attributable to common stockholders, basic and diluted	$ (6,112)	$ (14,558)
Net loss per share attributable to common stockholders, basic and diluted (in dollars per share)	$ (0.16)	$ (7.23)
Weighted-average common shares outstanding, basic and diluted (in shares)	37,308,084	2,013,839
Subscription and related services
Revenue:
Revenues	$ 15,599	$ 12,683
Payment processing fees
Revenue:
Revenue from contract with customer	11,707	11,557
Life sciences
Revenue:
Revenue from contract with customer	$ 6,090	$ 4,070